DocGo Inc. (DCGO) Stock Forecast
Data as of Oct 31, 2026Healthcare · Current price $0.25 (-9.85%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Nov 12, 2025 | Richard Close | Canaccord Genuity | $1.50 | +507.3% |
| May 9, 2024 | Richard Close | Canaccord Genuity | $5.00 | +1924.3% |
| Apr 10, 2024 | David Grossman | Stifel Nicolaus | $8.00 | +3138.9% |
| Apr 10, 2024 | David Larsen | BTIG | $11.00 | +4353.4% |
Top Analysts Covering DCGO
DCGO vs Sector & Market
| Metric | DCGO | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.33 | 2.25 | 2.41 |
| Analyst Count | 3 | 8 | 19 |
| Target Upside | +2264.4% | +153000.0% | +21.5% |
| P/E Ratio | -0.39 | 3.47 | 38.49 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $298M | $299M | $300M | 4 |
| 2027-12-31 | $314M | $319M | $324M | 4 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-2.01 | $-0.32 | $1.27 | 3 |
| 2027-12-31 | $-0.38 | $-0.19 | $-0.01 | 2 |
Frequently Asked Questions
What is the analyst consensus for DCGO?
The consensus among 3 analysts covering DocGo Inc. (DCGO) is Buy with an average price target of $5.84.
What is the highest price target for DCGO?
The highest price target for DCGO is $11.00, set by David Larsen at BTIG on 2024-04-10.
What is the lowest price target for DCGO?
The lowest price target for DCGO is $1.50, set by Richard Close at Canaccord Genuity on 2025-11-12.
How many analysts cover DCGO?
3 analysts have issued ratings for DocGo Inc. in the past 12 months.
Is DCGO a buy or sell right now?
Based on 3 analyst ratings, DCGO has a consensus rating of Buy (2.33/5) with a +2264.4% upside to the consensus target of $5.84.
What are the earnings estimates for DCGO?
Analysts estimate DCGO will report EPS of $-0.32 for the period ending 2026-12-31, with revenue estimated at $299M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.